|
|
||||||||
1 University Laboratory of
Physiology,
Administration of
nitric oxide (NO) donors in vivo is accompanied by a
baroreflex-mediated increase in heart rate (HR). In vitro, however, NO
donors can increase HR directly by stimulating a pathway that involves
NO, cGMP, and the hyperpolarization-activated current
(If). The aim
of this study was to assess the functional significance of this pathway
in vivo by testing whether NO donors can increase HR in the
anesthetized rabbit independent of the autonomic nervous system. New
Zealand White rabbits were vagotomized, cardiac sympathectomized, and
treated with propranolol (0.3 mg/kg iv). The NO donor molsidomine (0.2 mg/kg iv) caused a progressive increase (
) in HR (
HR, 14 ± 3 beats/min; P < 0.01). This effect was significantly reduced by the
If blocker
ZD-7288 (0.2 mg/kg iv;
HR, 2 ± 3 beats/min;
P = not significant).
Similar results were seen with sodium nitroprusside. The positive
chronotropic effect of sodium nitroprusside (50 µM) was confirmed in
the isolated working rabbit heart preparation (
HR, 17 ± 3 beats/min; P < 0.01). In conclusion,
NO donors exert a small, but significant, positive chronotropic effect
in vivo that is independent of the autonomic nervous system. These
results are also consistent with data in sinoatrial node cells that
show that NO donors increase HR by stimulating
If.
sodium nitroprusside; molsidomine; baroreflex; rabbit
This article has been cited by other articles:
![]() |
P. Studinger, R. Goldstein, and J. A. Taylor Mechanical and neural contributions to hysteresis in the cardiac vagal limb of the arterial baroreflex J. Physiol., September 15, 2007; 583(3): 1041 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kamendi, O. Dergacheva, X. Wang, Z.-G. Huang, E. Bouairi, C. Gorini, and D. Mendelowitz NO Differentially Regulates Neurotransmission to Premotor Cardiac Vagal Neurons in the Nucleus Ambiguus Hypertension, December 1, 2006; 48(6): 1137 - 1142. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Fellet, A. M. Balaszczuk, C. Arranz, J. J. Lopez-Costa, A. Boveris, and J. Bustamante Autonomic regulation of pacemaker activity: role of heart nitric oxide synthases Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1246 - H1254. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. O'Connor, J. C. Ousey, D. S. Gardner, A. L. Fowden, and D. A. Giussani Development of baroreflex function and hind limb vascular reactivity in the horse fetus J. Physiol., April 1, 2006; 572(1): 155 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cui, R. Zhang, T. E. Wilson, S. Witkowski, C. G. Crandall, and B. D. Levine Nitric oxide synthase inhibition does not affect regulation of muscle sympathetic nerve activity during head-up tilt Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2105 - H2110. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ramchandra, C. J. Barrett, and S. C. Malpas Chronic Blockade of Nitric Oxide Does Not Produce Hypertension in Baroreceptor Denervated Rabbits Hypertension, November 1, 2003; 42(5): 974 - 977. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Lipman, J. K. Salisbury, and J. A. Taylor Spontaneous Indices Are Inconsistent With Arterial Baroreflex Gain Hypertension, October 1, 2003; 42(4): 481 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Achan, M. Broadhead, M. Malaki, G. Whitley, J. Leiper, R. MacAllister, and P. Vallance Asymmetric Dimethylarginine Causes Hypertension and Cardiac Dysfunction in Humans and Is Actively Metabolized by Dimethylarginine Dimethylaminohydrolase Arterioscler. Thromb. Vasc. Biol., August 1, 2003; 23(8): 1455 - 1459. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Fadel, M. Stromstad, D. W. Wray, S. A. Smith, P. B. Raven, and N. H. Secher New insights into differential baroreflex control of heart rate in humans Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H735 - H743. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Herring, J. A. B. Zaman, and D. J. Paterson Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2318 - H2327. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Herring, L. Rigg, D. A Terrar, and D. J Paterson NO-cGMP pathway increases the hyperpolarisation-activated current, If, and heart rate during adrenergic stimulation Cardiovasc Res, December 1, 2001; 52(3): 446 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sener and F. G. Smith Nitric oxide modulates arterial baroreflex control of heart rate in conscious lambs in an age-dependent manner Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2255 - H2263. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Musialek and B. Casadei Nitrovasodilators and heart rate: more than the arterial baroreflex Cardiovasc Res, August 1, 2000; 47(2): 404 - 405. [Full Text] [PDF] |
||||
![]() |
R. M Mohan and D. J Paterson Activation of sulphonylurea-sensitive channels and the NO-cGMP pathway decreases the heart rate response to sympathetic nerve stimulation Cardiovasc Res, July 1, 2000; 47(1): 81 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hogan, A. Kardos, D. J. Paterson, and B. Casadei Effect of exogenous nitric oxide on baroreflex function in humans Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H221 - H227. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |